ROSEN, THE FIRST FILING FIRM, Urges TransMedics Group, Inc. Investors to Seek Guidance Before Key Deadline in Securities Lawsuit

ROSEN, TOP-RANKED GLOBAL CATASTROPHIC INVESTOR FIRM, ENCOURAGES TRANSMEDICS GROUP, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPENDING LOSSES FROM MARKET VOLATILITY

New York, NY - Rosen Law Firm, a global investor rights law firm, reminds investors of publicly traded company Transmedics Group, Inc. (NASDAQ: TMDX) of the importance of securing counsel to protect their investments from impending losses.

On March 17, 2023, Transmedics Group, Inc. announced that it had entered into a definitive agreement to be acquired by a leading global life sciences company. The all-cash transaction is valued at approximately $1.35 billion. The transaction is expected to close in the second half of 2023, subject to customary closing conditions.

The Rosen Law Firm urges investors to take immediate action to protect themselves from potential losses. The firm is seeking information on behalf of investors who may have purchased Transmedics Group, Inc. securities and suffered losses as a result of the company's announcement.

Rosen Law Firm has a proven track record of securing significant recoveries for investors in cases of corporate mismanagement, securities fraud, and other forms of investor harm. The firm has secured hundreds of millions of dollars in recoveries for investors in recent years, and is committed to protecting the rights of investors worldwide.

Investors who have suffered losses as a result of the company's announcement are encouraged to contact the Rosen Law Firm to discuss their options. The firm's experienced attorneys are available to provide guidance and representation to investors who have been harmed by the company's actions.

Rosen Law Firm is a global investor rights law firm that represents investors in securities-related cases. The firm has secured hundreds of millions of dollars in recoveries for investors in recent years, and is committed to protecting the rights of investors worldwide. For more information, please visit our website at www.rosenlegal.com. You can also contact us toll-free at 866-767-3653 or via email at [email address]. As a reminder, the filing of a complaint is not a guarantee of an favorable outcome and any investor or group of investors may choose to do nothing at all.